Q BioMed Inc (QBIO)
0.0000
0.00 (0.00%)
USD |
OTCM |
May 23, 09:35
Q BioMed Cash from Financing (Quarterly): 0.1114M for Feb. 28, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
February 28, 2023 | 0.1114M |
November 30, 2022 | 0.3877M |
August 31, 2022 | 0.35M |
May 31, 2022 | 0.00 |
February 28, 2022 | 0.17M |
November 30, 2021 | 1.753M |
August 31, 2021 | 0.7013M |
May 31, 2021 | 0.94M |
February 28, 2021 | 1.075M |
November 30, 2020 | 0.323M |
August 31, 2020 | 0.00 |
May 31, 2020 | 3.95M |
February 29, 2020 | 1.965M |
November 30, 2019 | 0.90M |
August 31, 2019 | 0.6125M |
May 31, 2019 | 0.0808M |
February 28, 2019 | 0.00 |
November 30, 2018 | 3.865M |
Date | Value |
---|---|
August 31, 2018 | 0.00 |
May 31, 2018 | 0.00 |
February 28, 2018 | 4.945M |
November 30, 2017 | -0.0134M |
August 31, 2017 | 2.384M |
May 31, 2017 | 2.50M |
February 28, 2017 | 0.07M |
November 30, 2016 | 2.008M |
August 31, 2016 | 0.2551M |
May 31, 2016 | 0.165M |
February 29, 2016 | 0.455M |
November 30, 2015 | 0.21M |
August 31, 2015 | 0.0002M |
May 31, 2015 | 0.00 |
February 28, 2015 | 0.00 |
November 30, 2014 | 0.00 |
August 31, 2014 | 0.025M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Aug 2020
3.95M
Maximum
May 2020
0.8325M
Average
0.5001M
Median
Cash from Financing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.597M |
Palatin Technologies Inc | 9.136M |
iBio Inc | 5.025M |
Theriva Biologics Inc | 0.00 |
Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.1382M |
Free Cash Flow | 2.180M |
Free Cash Flow Per Share (Quarterly) | -0.0013 |